DURAClone IM TCR Citations

The following scientific literature references describe clinical research uses of of the listed products for immunological biomarker assessment and discovery purposes. These products are for research use only and are not labeled for diagnostic use.

 

Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer.

Holl EK, Frazier VN, Landa K, Beasley GM, Hwang ES, Nair SK. Front Immunol. 2019 Jul 31;10:1767. doi: 10.3389/fimmu.2019.01767. eCollection 2019. 

 

Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers.

James A. Hutchinson, Kilian Weigand, Akinbami Adenugba, Katharina Kronenberg, Jan Haarer, Florian Zeman, Paloma Riquelme, Matthias Hornung, Norbert Ahrens, Hans J. Schlitt, Edward K. Geissler, Jens M. Werner. Front Immunol. 2018; 9: 146. Published online 2018 Feb 7. doi: 10.3389/fimmu.2018.00146. 

 

Immune expression in children with Wilms tumor: a pilot study

Holl EK, Routh JC, Johnston AW, Frazier V, Rice HE, Tracy ET, Nair SK. J Pediatr Urol. 2019 Mar 20. pii: S1477-5131(19)30069-5.

 

Clinical-scale manufacturing of γδ T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis

Lamb LS, Pillai S, Langford S, Bowersock J, Stasi AD, Saad A. Bone Marrow Transplant. 2018 Mar 7.

 

The detailed distribution of T cell subpopulations in immune-stable renal allograft recipients: a single center study

Quan Zhuang, Bo Peng, Wei Wei, Hang Gong, Meng Yu, Min Yang, Lian Liu, Yingzi Ming PeerJ. 2019; 7: e6417.